Carlos Cruchaga
Affiliations: | Washington University School of Medicine, St. Louis, MO, United States |
Area:
Alzheimer's, genetics, genomics, quantitative traits, WES, WGS, proteomicsGoogle:
"Carlos Cruchaga"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Juan Jose Martinez | grad student | Universidad de Navarra | |
| Alison M. Goate | post-doc | ||
| Pau Pastor | post-doc |
Children
Sign in to add trainee| Umber Dube | grad student | Washington University School of Medicine | |
| Maria Victoria Fernandez | grad student | Washington University School of Medicine | |
| Laura Ibanez | grad student | Washington University School of Medicine | |
| Peter Jin | grad student | Washington University School of Medicine | |
| Chengran Yang | grad student | Washington University School of Medicine | |
| Yuetiva Deming | grad student | 2011-2017 | Washington University School of Medicine |
| Oscar Harari | grad student | 2013-2019 | Washington University School of Medicine |
| Zeran Li | grad student | 2015-2019 | Washington University School of Medicine |
| Bruno A. Benitez | post-doc | Washington University School of Medicine | |
| Jenny Lord | post-doc | Wellcome Sanger Institute | |
| Yuetiva Deming | post-doc | 2017-2018 | Washington University School of Medicine in St. Louis |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dammer EB, Shantaraman A, Ping L, et al. (2024) Proteomic analysis of Alzheimer's disease cerebrospinal fluid reveals alterations associated with ε4 and atomoxetine treatment. Science Translational Medicine. 16: eadn3504 |
| Narasimhan S, Holtzman DM, Apostolova LG, et al. (2024) Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway. Nature Neuroscience |
| Manzoni C, Kia DA, Ferrari R, et al. (2024) Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia. American Journal of Human Genetics |
| Cruchaga C, Bradley J, Western D, et al. (2024) Novel early-onset Alzheimer-associated genes influence risk through dysregulation of glutamate, immune activation, and intracell signaling pathways. Research Square |
| Panyard DJ, Reus LM, Ali M, et al. (2024) Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Hermes S, Cady J, Armentrout S, et al. (2024) Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores. Journal of Alzheimer's Disease : Jad |
| Wagemann O, Liu H, Wang G, et al. (2024) Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial. Jama Neurology |
| Levin J, Baiardi S, Quadalti C, et al. (2024) α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Wisch JK, McKay NS, Boerwinkle AH, et al. (2024) Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 23: 500-510 |
| Yi H, Yang Q, Repaci C, et al. (2024) TOPMed imputed genomics enhances genomic atlas of the human proteome in brain, cerebrospinal fluid, and plasma. Scientific Data. 11: 387 |